Bluejay Diagnostics (BJDX) Income from Continuing Operations (2020 - 2026)

Bluejay Diagnostics has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 1919972.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 1919972.0, down 2.61% year-over-year; the trailing twelve-month figure through Mar 2026 was 6904878.0 (up 5.6% YoY), and the FY2025 annual result was 6856252.0, up 12.62% from the prior year.
• Income from Continuing Operations came in at 1919972.0 for Q1 2026 at Bluejay Diagnostics, down from 1430391.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1430391.0 in Q4 2025 to a low of 2903688.0 in Q2 2023.
• The 5-year median for Income from Continuing Operations is 2068261.0 (2022), against an average of 2132152.41.
• Across the five-year window, Income from Continuing Operations sank 786.91% in 2022 and soared 39.38% in 2024, its largest moves.
• Bluejay Diagnostics' Income from Continuing Operations stood at 2453612.0 in 2022, then gained by 2.73% to 2386724.0 in 2023, then jumped by 39.38% to 1446741.0 in 2024, then climbed by 1.13% to 1430391.0 in 2025, then slumped by 34.23% to 1919972.0 in 2026.
• The last three Income from Continuing Operations figures came in at 1919972.0 (Q1 2026), 1430391.0 (Q4 2025), and 1598186.0 (Q3 2025), per Business Quant data.